Product Information
LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1535 per EA under NDC 68180085473. Its NADAC has been published 351 times since Jan 15, 2020.
FDA first approved this application on Jan 18, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180085473
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091425FDA Approved
1/18/2013
TE Code
AB1
On Market Since
7/3/2019
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 351 times since Jan 15, 2020, and over the history we have for it it has declined 50.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.3372 (Jun 10, 2020) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.1925 |
| Average price | $0.1977 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 351 |
| Tracking since | Jan 15, 2020 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.1535 per EA (NDC 68180085473), effective Sep 30, 2026.
How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has declined 50.1%. It has been tracked across 351 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Since Jan 15, 2020, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.3372 (Jun 10, 2020), with a median of $0.1925 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1135 per EA — about 26% below LEVONOR-ETH ESTRAD 0.1-0.02 MG.
Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?
LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 68180085473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.